Researchers have captured the first cryo-electron microscopy snapshots of the cold-sensing ion channel TRPM8 in its open state at low temperature, identifying the membrane lipid PIP2 as the molecular switch that forces the channel’s pore open. The work provides a structural explanation for how nerve endings in the skin, mouth, and eyes convert a drop in temperature into an electrical signal the brain reads as “cold.” Because TRPM8 is also linked to chronic pain, migraine, and other conditions, the findings give drug designers a precise target they have lacked until now.
What TRPM8 Does and Why It Matters
TRPM8 is a calcium-permeable, nonselective cation channel expressed in sensory neurons. It sits in the membranes of nerve fibers that reach the skin, oral cavity, and eyes, responding to cold temperatures roughly below 25 degrees Celsius and to chemical cooling agents such as menthol. When the channel opens, calcium and sodium ions rush into the neuron, firing the signal that produces the familiar chill sensation.
That basic biology has been established for years. The harder question has been mechanical: what physical event inside the protein flips the channel from closed to open? Earlier structural studies captured TRPM8 only in non-conducting conformations, leaving the final step of activation out of reach. The new work fills that gap by imaging the channel under conditions that actually trigger it.
Freezing the Channel Open at 4 Degrees
The research team used cryo-EM to solve structures of TRPM8 at 4 degrees Celsius, cold enough to activate the channel. At that temperature, the images revealed an open pore conformation for the first time, with the central gate clearly dilated. Within the density maps, the lipid phosphatidylinositol 4,5-bisphosphate, or PIP2, was docked into a hydrophobic cleft in the transmembrane domain. That placement is significant because it shows PIP2 physically wedged into a pocket that helps hold the gate open, rather than acting from a distance through diffuse membrane effects.
Earlier cryo-EM campaigns had established that PIP2 and cooling compounds bind in the transmembrane region, but those structures all exhibited non-conducting conformations. Capturing the open state required cooling the sample to a temperature that genuinely activates the protein, a technical challenge that previous groups did not overcome. The difference between imaging a resting channel and an active one is the difference between photographing a locked door and a door mid-swing: many of the same parts are visible, but their relative positions tell you whether ions can pass.
The new structures also include bound agonists that mimic menthol, ensuring that the channel was not only cold-exposed but chemically stimulated. This combination of low temperature, agonist, and PIP2 recreates the conditions experienced by sensory nerve endings in the periphery, making the observed open state physiologically relevant rather than an artifact of the imaging process.
PIP2 as the Gating Trigger
The lipid’s role is not simply structural scaffolding. A 2019 study published in Science showed that TRPM8 function depends critically on PIP2 and mapped two distinct binding modes for the lipid on the cytosolic side of the channel. That work demonstrated that PIP2 allosterically couples to cooling agonists such as icilin and the menthol analog WS-12, meaning the lipid’s presence changes how the protein responds to these chemicals. Electrophysiology experiments using inside-out membrane patches confirmed that stripping PIP2 from the inner leaflet silences the channel regardless of temperature, pointing to the lipid as an essential cofactor rather than a mere enhancer.
A follow-up study published in October 2022 extended the picture by solving closed, intermediate, and pre-open states of mouse TRPM8 along a ligand- and PIP2-dependent activation pathway. That work, which used a combination of cryo-EM and functional assays, showed that small local rearrangements triggered by PIP2 and agonist binding propagate through the protein to reorient the S6 gate helix that lines the pore. In simple terms, PIP2 acts as a molecular lever: cold or menthol alone nudges the channel toward opening, but the lipid’s engagement is required to complete the movement and fully clear the gate.
The binding sites for PIP2 and cooling agents sit on opposite sides of the fourth transmembrane segment, known as S4. That geometry means the two inputs converge on the same structural element from different directions, explaining why both are needed for full activation. It is akin to two hands turning the same doorknob from opposite sides of a door: either hand alone can start the motion, but both together can generate the torque needed to swing the door wide.
From Structural Snapshots to Sensory Experience
The structural work on TRPM8 fits into a broader effort to understand how transient receptor potential channels encode temperature and chemical stimuli. Reviews of the family have emphasized that the melastatin subfamily integrates multiple signals, including voltage, lipids, and small molecules, to control ion flux. TRPM8 is a particularly clear example of this integrative logic: voltage biases the channel toward opening, PIP2 stabilizes permissive conformations, and cold or menthol provide the final push.
In sensory neurons, this molecular choreography converts a modest drop in skin temperature into a burst of electrical activity. As TRPM8 channels open, calcium and sodium enter the nerve terminal, depolarizing the membrane and triggering action potentials that travel to the spinal cord and brainstem. The central nervous system interprets the frequency and pattern of these impulses as coolness or outright cold, depending on how many fibers are activated and for how long.
TRPM8’s role extends beyond simple temperature detection. Genetic and pharmacological studies, summarized in broader analyses of somatosensory ion channels, implicate TRPM8 in neuropathic pain, migraine, and dry eye disease. In these contexts, the same cold-sensing machinery becomes maladaptive: heightened TRPM8 activity can make innocuous cool stimuli painful, while reduced activity may blunt protective reflexes. Understanding how PIP2 and temperature shape the channel’s open probability therefore has implications not just for sensation but for pathology.
Why Coverage Often Overstates the Novelty
Media summaries of this research arc often frame each new structure as a standalone breakthrough that “finally” reveals how cold is sensed. The reality is more incremental and, in some ways, more impressive. The 2019 Science paper identified where PIP2 and agonists bind and how lipid depletion shuts down activity. The 2022 study traced the conformational pathway connecting these binding events to partial opening of the gate. The latest cryo-EM work at 4 degrees Celsius adds the missing endpoint: a fully open pore under conditions that genuinely activate the channel.
Taken together, these papers now span the full gating cycle, from resting to intermediate to open, under physiologically relevant combinations of temperature, voltage, lipid, and ligand. Treating any single structure as the whole story obscures how structural biology typically advances: by layering multiple snapshots, each answering a specific question the last one left unresolved. The emerging picture of TRPM8 gating is a composite assembled over years, not a eureka moment captured in one figure.
What We Still Do Not Know About Cold
A genuine open question remains around temperature itself. PIP2 binding and agonist binding are now well mapped, but the mechanism by which cold physically alters the protein, independent of ligand, is still debated. The new 4-degree structures capture the outcome of cold activation, not necessarily the initial thermosensory event. It is unclear whether cooling primarily changes lipid packing around the channel, shifts the intrinsic flexibility of key helices, or alters water networks lining the pore and cavities.
Some models propose that TRPM8 contains specific thermo-sensitive domains whose enthalpy and entropy changes bias the channel toward opening as temperature drops. Others emphasize the contribution of the surrounding membrane, where PIP2 and other phospholipids may reorganize in ways that favor the open state. At present, the structural data alone cannot distinguish cleanly between these scenarios, and time-resolved or single-molecule approaches will likely be needed to watch the earliest steps of cold sensing in action.
For drug developers, however, the lack of a complete thermodynamic model is less limiting than the absence of an atomic framework once was. With an open TRPM8 structure in hand, medicinal chemists can now design small molecules to stabilize either the conducting or non-conducting conformation, fine-tuning sensitivity to cold without necessarily abolishing it. That prospect, grounded in the combined insights of several structural and functional studies, illustrates how understanding a single lipid wedged in a protein pocket can ultimately reshape how we manage pain and sensory disorders.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
